NEW YORK (Reuters Health) - A new analysis of nearly a dozen studies testing vitamin D in older individuals has concluded that it takes a daily dose of at least 800 international units (IU) to ...

Two doses of vitamin D were investigated for their potential to have a positive impact on systolic and diastolic blood pressures when administered in conjunction with calcium. Outcomes in a new ...

BARCELONA, Spain — The addition of high-dose vitamin D supplementation to standard chemotherapy plus bevacizumab did not result in a significant progression-free survival benefit in patients with ...

A bottle of B-complex vitamin pills. Image by By Ragesoss CC BY-SA 3.0 A bottle of B-complex vitamin pills. Image by By Ragesoss CC BY-SA 3.0 Some studies have reported that taking vitamin D may help ...

Medically reviewed by Patricia Mikula, PharmD Key Takeaways Vitamin D supplements, combined with diet and exercise, may help ...

Higher doses of vitamin D3 supplementation did not significantly reduce cardiac biomarkers in older adults with low serum vitamin D levels. The STURDY trial found no significant differences in ...

Using significantly higher doses of vitamin D than recommended for five years did not affect the incidence of type 2 diabetes in elderly men and women, according to a new study from the University of ...

High-dose vitamin D reduced disease activity in early MS and CIS compared with placebo. Patients taking vitamin D had a longer time to disease activity: 432 days versus 224 days. No severe adverse ...

New research shows that if you already have enough vitamin D, taking even high doses in supplement form won't lower your odds for the disease High-dose vitamin D also didn't help control blood sugar ...

Vitamin D supplements are linked to many health benefits, including decreasing the chance of heart disease, supporting immune function, and aiding weight loss. New research suggests that calcium and ...

New clinical insights reveal how Vitamin D impacts your lipid profile, but experts warn that high doses could interfere with common heart medications.

A multicenter, double-blind, placebo-controlled study conducted over 2 years enrolled 303 patients ages 18 to 55 years with recent CIS suggestive of MS. Disease activity was observed in a smaller ...